Literature DB >> 27941027

The lipid droplet-associated protein perilipin 3 facilitates hepatitis C virus-driven hepatic steatosis.

Daniel Ferguson1,2, Jun Zhang2, Matthew A Davis2, Robert N Helsley1, Lise-Lotte Vedin3, Richard G Lee3, Rosanne M Crooke3, Mark J Graham3, Daniela S Allende4, Paolo Parini3, J Mark Brown5.   

Abstract

Hepatitis C virus (HCV) is an enveloped RNA virus responsible for 170 million cases of viral hepatitis worldwide. Over 50% of chronically infected HCV patients develop hepatic steatosis, and steatosis can be induced by expression of HCV core protein (core) alone. Additionally, core must associate with cytoplasmic lipid droplets (LDs) for steatosis development and viral particle assembly. Due to the importance of the LD as a key component of hepatic lipid storage and as a platform for HCV particle assembly, it seems this dynamic subcellular organelle is a gatekeeper in the pathogenesis of viral hepatitis. Here, we hypothesized that core requires the host LD scaffold protein, perilipin (PLIN)3, to induce hepatic steatosis. To test our hypothesis in vivo, we have studied core-induced hepatic steatosis in the absence or presence of antisense oligonucleotide-mediated knockdown of PLIN3. PLIN3 knockdown blunted HCV core-induced steatosis in transgenic mice fed either chow or a moderate fat diet. Collectively, our studies demonstrate that the LD scaffold protein, PLIN3, is essential for HCV core-induced hepatic steatosis and provide new insights into the pathogenesis of HCV.
Copyright © 2017 by the American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  lipid droplets; lipoproteins/metabolism; liver; triglyceride

Mesh:

Substances:

Year:  2016        PMID: 27941027      PMCID: PMC5282958          DOI: 10.1194/jlr.M073734

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  73 in total

1.  A single centrifugation method for isolating fat droplets from cells and tissues.

Authors:  Lydia-Ann L S Harris; Trevor M Shew; James R Skinner; Nathan E Wolins
Journal:  J Lipid Res       Date:  2012-02-11       Impact factor: 5.922

2.  Enhancement of de novo fatty acid biosynthesis in hepatic cell line Huh7 expressing hepatitis C virus core protein.

Authors:  Masayoshi Fukasawa; Yasuhito Tanaka; Shigeko Sato; Yujin Ono; Yuko Nitahara-Kasahara; Tetsuro Suzuki; Tatsuo Miyamura; Kentaro Hanada; Masahiro Nishijima
Journal:  Biol Pharm Bull       Date:  2006-09       Impact factor: 2.233

Review 3.  Unique ties between hepatitis C virus replication and intracellular lipids.

Authors:  Eva Herker; Melanie Ott
Journal:  Trends Endocrinol Metab       Date:  2011-04-15       Impact factor: 12.015

4.  Reduction of TIP47 improves hepatic steatosis and glucose homeostasis in mice.

Authors:  Rotonya M Carr; Rajesh T Patel; Vandana Rao; Ravindra Dhir; Mark J Graham; Rosanne M Crooke; Rexford S Ahima
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-02-29       Impact factor: 3.619

5.  Adipose triglyceride lipase-mediated lipolysis of cellular fat stores is activated by CGI-58 and defective in Chanarin-Dorfman Syndrome.

Authors:  Achim Lass; Robert Zimmermann; Guenter Haemmerle; Monika Riederer; Gabriele Schoiswohl; Martina Schweiger; Petra Kienesberger; Juliane G Strauss; Gregor Gorkiewicz; Rudolf Zechner
Journal:  Cell Metab       Date:  2006-05       Impact factor: 27.287

6.  The use of stable isotope-labeled glycerol and oleic acid to differentiate the hepatic functions of DGAT1 and -2.

Authors:  Jenson Qi; Wensheng Lang; John G Geisler; Ping Wang; Ioanna Petrounia; Selyna Mai; Charles Smith; Hossein Askari; Geoffrey T Struble; Robyn Williams; Sanjay Bhanot; Brett P Monia; Shariff Bayoumy; Eugene Grant; Gary W Caldwell; Matthew J Todd; Yin Liang; Micheal D Gaul; Keith T Demarest; Margery A Connelly
Journal:  J Lipid Res       Date:  2012-04-03       Impact factor: 5.922

7.  The serine hydrolase ABHD6 Is a critical regulator of the metabolic syndrome.

Authors:  Gwynneth Thomas; Jenna L Betters; Caleb C Lord; Amanda L Brown; Stephanie Marshall; Daniel Ferguson; Janet Sawyer; Matthew A Davis; John T Melchior; Lawrence C Blume; Allyn C Howlett; Pavlina T Ivanova; Stephen B Milne; David S Myers; Irina Mrak; Vera Leber; Christoph Heier; Ulrike Taschler; Jacqueline L Blankman; Benjamin F Cravatt; Richard G Lee; Rosanne M Crooke; Mark J Graham; Robert Zimmermann; H Alex Brown; J Mark Brown
Journal:  Cell Rep       Date:  2013-10-03       Impact factor: 9.423

8.  Hepatic steatosis in hepatitis C is a storage disease due to HCV interaction with microsomal triglyceride transfer protein (MTP).

Authors:  Silvia Mirandola; David Bowman; Mahmood M Hussain; Alfredo Alberti
Journal:  Nutr Metab (Lond)       Date:  2010-02-23       Impact factor: 4.169

Review 9.  Hepatitis C virus core protein, lipid droplets and steatosis.

Authors:  P Roingeard; C Hourioux
Journal:  J Viral Hepat       Date:  2007-12-17       Impact factor: 3.728

10.  Structural determinants that target the hepatitis C virus core protein to lipid droplets.

Authors:  Steeve Boulant; Roland Montserret; R Graham Hope; Maxime Ratinier; Paul Targett-Adams; Jean-Pierre Lavergne; Francois Penin; John McLauchlan
Journal:  J Biol Chem       Date:  2006-05-16       Impact factor: 5.157

View more
  9 in total

1.  Role of Mineralocorticoid Receptor in Adipogenesis and Obesity in Male Mice.

Authors:  Daniel Ferguson; Irina Hutson; Eric Tycksen; Terri A Pietka; Kevin Bauerle; Charles A Harris
Journal:  Endocrinology       Date:  2020-02-01       Impact factor: 4.736

2.  Lack of TRPV1 Channel Modulates Mouse Gene Expression and Liver Proteome with Glucose Metabolism Changes.

Authors:  José Thalles Lacerda; Patrícia R L Gomes; Giovanna Zanetti; Nathana Mezzalira; Otoniel G Lima; Leonardo V M de Assis; Ali Guler; Ana Maria Castrucci; Maria Nathália Moraes
Journal:  Int J Mol Sci       Date:  2022-06-24       Impact factor: 6.208

3.  Perilipins at a glance.

Authors:  Charles P Najt; Mahima Devarajan; Douglas G Mashek
Journal:  J Cell Sci       Date:  2022-03-09       Impact factor: 5.235

4.  Mouse Embryonic Fibroblasts Protect ob/ob Mice From Obesity and Metabolic Complications.

Authors:  Daniel Ferguson; Mitchell Blenden; Irina Hutson; Yingqiu Du; Charles A Harris
Journal:  Endocrinology       Date:  2018-09-01       Impact factor: 4.736

5.  Feedback activation of GATA1/miR-885-5p/PLIN3 pathway decreases sunitinib sensitivity in clear cell renal cell carcinoma.

Authors:  Dayong Yao; Shunyao Xia; Chengjun Jin; Weiming Zhao; Wenjia Lan; Zan Liu; Youcheng Xiu
Journal:  Cell Cycle       Date:  2020-08-12       Impact factor: 4.534

6.  Obesity-linked suppression of membrane-bound O-acyltransferase 7 (MBOAT7) drives non-alcoholic fatty liver disease.

Authors:  Robert N Helsley; Venkateshwari Varadharajan; Amanda L Brown; Anthony D Gromovsky; Rebecca C Schugar; Iyappan Ramachandiran; Kevin Fung; Mohammad Nasser Kabbany; Rakhee Banerjee; Chase K Neumann; Chelsea Finney; Preeti Pathak; Danny Orabi; Lucas J Osborn; William Massey; Renliang Zhang; Anagha Kadam; Brian E Sansbury; Calvin Pan; Jessica Sacks; Richard G Lee; Rosanne M Crooke; Mark J Graham; Madeleine E Lemieux; Valentin Gogonea; John P Kirwan; Daniela S Allende; Mete Civelek; Paul L Fox; Lawrence L Rudel; Aldons J Lusis; Matthew Spite; J Mark Brown
Journal:  Elife       Date:  2019-10-17       Impact factor: 8.140

Review 7.  Modulation of Lipid Droplet Metabolism-A Potential Target for Therapeutic Intervention in Flaviviridae Infections.

Authors:  Jingshu Zhang; Yun Lan; Sumana Sanyal
Journal:  Front Microbiol       Date:  2017-11-28       Impact factor: 5.640

Review 8.  Lipid Bodies as Sites of Prostaglandin E2 Synthesis During Chagas Disease: Impact in the Parasite Escape Mechanism.

Authors:  Patrícia E de Almeida; Daniel A M Toledo; Gabriel S C Rodrigues; Heloisa D'Avila
Journal:  Front Microbiol       Date:  2018-03-20       Impact factor: 5.640

Review 9.  Methods for Lipid Droplet Biophysical Characterization in Flaviviridae Infections.

Authors:  Ana S Martins; Ivo C Martins; Nuno C Santos
Journal:  Front Microbiol       Date:  2018-08-21       Impact factor: 5.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.